405
Views
1
CrossRef citations to date
0
Altmetric
Clinical Research

Functional vitamin B12 deficiency is a consistent feature in hospital admissions for neurological disorders due to the use of nitrous oxide

, , , , , & show all
Pages 674-679 | Received 10 Apr 2023, Accepted 18 Oct 2023, Published online: 02 Nov 2023

References

  • Baum VC. When nitrous oxide is no laughing matter: nitrous oxide and pediatric anesthesia. Paediatr Anaesth. 2007;17(9):824–830. doi: 10.1111/j.1460-9592.2007.02264.x.
  • Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology. 2008;109(4):707–722. doi: 10.1097/ALN.0b013e3181870a17.
  • Kondo H, Osborne ML, Kolhouse JF, et al. Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats. J Clin Invest. 1981;67(5):1270–1283. doi: 10.1172/jci110155.
  • Christensen B, Guttormsen AB, Schneede J, et al. Preoperative methionine loading enhances restoration of the cobalamin-dependent enzyme methionine synthase after nitrous oxide anesthesia. Anesthesiology. 1994;80(5):1046–1056. doi: 10.1097/00000542-199405000-00014.
  • Yamada K, Gravel RA, Toraya T, et al. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc Natl Acad Sci U S A. 2006;103(25):9476–9481. doi: 10.1073/pnas.0603694103.
  • Dorris RL. The effect of nitrous oxide on S-adenosylmethionine levels in mouse brain. J Pharm Pharmacol. 1991;43(5):369–370. doi: 10.1111/j.2042-7158.1991.tb06708.x.
  • Gernez E, Deheul S, Tard C, et al. Plasma methionine and clinical severity in nitrous oxide consumption. Toxics. 2022;11(1):12. doi: 10.3390/toxics11010012.
  • Garakani A, Jaffe RJ, Savla D, et al. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016;25(5):358–369. doi: 10.1111/ajad.12372.
  • Yu M, Qiao Y, Li W, et al. Analysis of clinical characteristics and prognostic factors in 110 patients with nitrous oxide abuse. Brain Behav. 2022;12:e2533.
  • Brunt TM, van den Brink W, van Amsterdam J. Mechanisms involved in the neurotoxicity and abuse liability of nitrous oxide: a narrative review. Int J Mol Sci. 2022;23(23):14747. doi: 10.3390/ijms232314747.
  • Vodovar D, Care W, Batisse A, et al. Vitamin B12 inactivation may not be the only cause of acquired peripheral neuropathy in chronic nitrous oxide users. Br J Clin Pharmacol. 2022;88(1):356–357. doi: 10.1111/bcp.14930.
  • Dufayet L, Caré W, Laborde-Casterot H, et al. Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France. Rev Med Interne. 2022;43(7):402–405. doi: 10.1016/j.revmed.2022.06.004.
  • Van Aerts L, de Morais J, Evans-Brown M, et al. European Monitoring Centre for Drugs and Drug Addiction (2022), Recreational use of nitrous oxide: a growing concern for Europe. Luxembourg: Publications Office of the European Union. doi: 10.2810/2003.
  • Kaar SJ, Ferris J, Waldron J, et al. Up, the rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. J Psychopharmacol. 2016;30(4):395–401. doi: 10.1177/0269881116632375.
  • van Riel AJ H P, Hunault C, van den Hengel-Koot, et al. Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch poisons information center. Int J Drug Policy. 2022;100:103519. doi: 10.1016/j.drugpo.2021.103519.
  • Redmond J, Cruse B, Kiers L. Nitrous oxide-induced neurological disorders: an increasing public health concern. Intern Med J. 2022;52(5):740–744. doi: 10.1111/imj.15544.
  • Micallef J, Mallaret M, Lapeyre-Mestre M, et al. Warning on increased serious health complications related to non-medical use of nitrous oxide. Therapie. 2021;76(1):53–54. doi: 10.1016/j.therap.2020.01.001.
  • Largeau B, Karam A, Potey C, et al. Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels. Eur J Neurol. 2022;29(8):2173–2180. doi: 10.1111/ene.15370.
  • Chen W, Si Z, Bi Y, et al. An unusual case of subacute combined degeneration due to nitrous oxide abuse, which relapsed after bariatric surgery: a case report. Medicine . 2022;101(35):e30442. doi: 10.1097/MD.0000000000030442.
  • Alt RS, Morrissey RP, Gang MA, et al. Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse. J Emerg Med. 2011;41(4):378–380. doi: 10.1016/j.jemermed.2010.04.020.
  • Saloojee Y, Cole P. Estimation of nitrous oxide in blood. Gas chromatographic analysis of trace or analgesic levels. Anaesthesia. 1978;33(9):779–783. doi: 10.1111/j.1365-2044.1978.tb08493.x.
  • Oussalah A, Julien M, Levy J, et al. Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis. J Clin Med. 2019;8(4):551. doi: 10.3390/jcm8040551.
  • Grzych G, Deheul S, Gernez E, et al. Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study. J Neurol. 2023;270(4):2237–2245. doi: 10.1007/s00415-023-11570-z.
  • Berling E, Fargeot G, Aure K, et al. Nitrous oxide-induced predominantly motor neuropathies: a follow-up study. J Neurol. 2022;269(5):2720–2726. doi: 10.1007/s00415-021-10858-2.
  • Einsiedler M, Voulleminot P, Demuth S, et al. A rise in cases of nitrous oxide abuse: neurological complications and biological findings. J Neurol. 2022;269(2):577–582. doi: 10.1007/s00415-021-10702-7.
  • Rothen J-P, Walter PN, Tsakiris DA, et al. Identification of patients with cobalamin deficiency crucially depends on the diagnostic strategy. Clin Lab. 2021;67(5):1229–1235. doi: 10.7754/Clin.Lab.2020.200912.
  • Zheng D, Ba F, Bi G, et al. The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature. J Neurol. 2020;267(2):422–429. doi: 10.1007/s00415-019-09600-w.
  • Temple C, Horowitz BZ. Nitrous oxide abuse induced subacute combined degeneration despite patient initiated B12 supplementation. Clin Toxicol. 2022;60(7):872–875. doi: 10.1080/15563650.2022.2046772.
  • Waclawik AJ, Luzzio CC, Juhasz-Pocsine K, et al. Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels. WMJ. 2003;102:5.
  • Desouza C, Keebler M, McNamara DB, et al. Drugs affecting homocysteine metabolism: impact on cardiovascular risk. Drugs. 2002;62(4):605–616. doi: 10.2165/00003495-200262040-00005.
  • Gerrard A, Dawson C. Homocystinuria diagnosis and management: it is not all classical. J Clin Pathol. 2022;75(11):744–750. doi: 10.1136/jcp-2021-208029.
  • Inquimbert C, Maitre Y, Moulis E, et al. Recreational nitrous oxide use and associated factors among health profession students in France. Int J Environ Res Public Health. 2022;19(9):5237. doi: 10.3390/ijerph19095237.
  • Cohen L, Duroy D, Perozziello A, et al. A cross-sectional study: nitrous oxide abuse in Parisian medical students. Am J Addict. 2023;32(1):60–65. doi: 10.1111/ajad.13363.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.